ArticleScientific reports2026
A sensor-fault resilient artificial pancreas using type-3 fuzzy logic and predictive controls.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We propose a fault-tolerant artificial pancreas architecture for type 1 diabetes management that leverages advanced artificial intelligence (AI) methods. The system combines a step-forward predictive controller with a type-3 fuzzy logic system (FLS) in a dual-loop structure, augmented by a real-time sensor fault detection and compensation unit. The fault detection unit uses fuzzy prediction to estimate and correct sensor fault coefficients, thereby mitigating the impact of corrupted glucose measurements. Closed-loop stability is established through Lyapunov-based analysis, which informs the design of the adaptive compensator. Performance was evaluated using simulation studies on a modified Bergman model that incorporates patient variability and external disturbances. Results show that the proposed AI-based controller achieves greater robustness, adaptability, and fault tolerance compared with conventional control approaches. These findings demonstrate the promise of integrating predictive control with fuzzy logic for reliable intelligent healthcare systems, offering new opportunities for safe and effective AI-driven solutions in biomedical engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.